These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1716470)

  • 41. Relationships of Cerebrospinal Fluid Monoamine Metabolite Levels With Clinical Variables in Major Depressive Disorder.
    Yoon HS; Hattori K; Ogawa S; Sasayama D; Ota M; Teraishi T; Kunugi H
    J Clin Psychiatry; 2017; 78(8):e947-e956. PubMed ID: 28749090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluid.
    Mårtensson B; Nyberg S; Toresson G; Brodin E; Bertilsson L
    Acta Psychiatr Scand; 1989 Jun; 79(6):586-96. PubMed ID: 2475012
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CSF monoamine metabolites in schizophrenic patients.
    Gattaz WF; Waldmeier P; Beckmann H
    Acta Psychiatr Scand; 1982 Nov; 66(5):350-60. PubMed ID: 6184954
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K
    No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationships between clinical symptoms and monoamine metabolite concentrations in biochemically defined subgroups of depressed patients.
    Nordin C
    Acta Psychiatr Scand; 1988 Dec; 78(6):720-9. PubMed ID: 2464903
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites.
    Potter WZ; Scheinin M; Golden RN; Rudorfer MV; Cowdry RW; Calil HM; Ross RJ; Linnoila M
    Arch Gen Psychiatry; 1985 Dec; 42(12):1171-7. PubMed ID: 2416297
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CSF tau, Aβ42, and MHPG differentiate dementia with Lewy bodies from Alzheimer's disease.
    Aerts MB; Esselink RA; Claassen JA; Abdo WF; Bloem BR; Verbeek MM
    J Alzheimers Dis; 2011; 27(2):377-84. PubMed ID: 21841257
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Venlafaxine but not bupropion decreases cerebrospinal fluid 5-hydroxyindoleacetic acid in unipolar depression.
    Little JT; Ketter TA; Mathé AA; Frye MA; Luckenbaugh D; Post RM
    Biol Psychiatry; 1999 Feb; 45(3):285-9. PubMed ID: 10023503
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical studies of the cholinergic deficit in Alzheimer's disease. I. Neurochemical and neuroendocrine studies.
    Davis BM; Mohs RC; Greenwald BS; Mathé AA; Johns CA; Horvath TB; Davis KL
    J Am Geriatr Soc; 1985 Nov; 33(11):741-8. PubMed ID: 2414354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
    Soininen H; MacDonald E; Rekonen M; Riekkinen PJ
    Acta Neurol Scand; 1981 Aug; 64(2):101-7. PubMed ID: 6172950
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment.
    Stuerenburg HJ; Ganzer S; Müller-Thomsen T
    Neuro Endocrinol Lett; 2004 Dec; 25(6):435-7. PubMed ID: 15665806
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monoamine metabolites in the CSF of epileptic patients.
    Laxer KD; Sourkes TL; Fang TY; Young SN; Gauthier SG; Missala K
    Neurology; 1979 Aug; 29(8):1157-61. PubMed ID: 37460
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuropsychological profile linked to low dopamine: in Alzheimer's disease, major depression, and Parkinson's disease.
    Wolfe N; Katz DI; Albert ML; Almozlino A; Durso R; Smith MC; Volicer L
    J Neurol Neurosurg Psychiatry; 1990 Oct; 53(10):915-7. PubMed ID: 2266376
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of antidepressants on the cerebrospinal fluid homovanillic acid/5-hydroxyindoleacetic acid ratio.
    Risby ED; Hsiao JK; Sunderland T; Agren H; Rudorfer MV; Potter WZ
    Clin Pharmacol Ther; 1987 Nov; 42(5):547-54. PubMed ID: 2445515
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF.
    Nikisch G; Baumann P; Wiedemann G; Kiessling B; Weisser H; Hertel A; Yoshitake T; Kehr J; Mathé AA
    J Clin Psychopharmacol; 2010 Oct; 30(5):496-503. PubMed ID: 20814316
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder.
    Swedo SE; Leonard HL; Kruesi MJ; Rettew DC; Listwak SJ; Berrettini W; Stipetic M; Hamburger S; Gold PW; Potter WZ
    Arch Gen Psychiatry; 1992 Jan; 49(1):29-36. PubMed ID: 1370197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Simultaneous determination of four monoamine metabolites and serotonin in cerebrospinal fluid by "high-performance" liquid chromatography with electrochemical detection; application for patients with Alzheimer's disease.
    Koyama E; Minegishi A; Ishizaki T
    Clin Chem; 1988 Apr; 34(4):680-4. PubMed ID: 2452037
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients.
    Mann JJ; Malone KM
    Biol Psychiatry; 1997 Jan; 41(2):162-71. PubMed ID: 9018386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Concentration gradient of CSF monoamine metabolites in children and adolescents.
    Kruesi MJ; Swedo SE; Hamburger SD; Potter WZ; Rapoport JL
    Biol Psychiatry; 1988 Sep; 24(5):507-14. PubMed ID: 2458775
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Consistent evidence for a biological subtype of depression characterized by low CSF monoamine levels.
    Gibbons RD; Davis JM
    Acta Psychiatr Scand; 1986 Jul; 74(1):8-12. PubMed ID: 2429500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.